The Pharma Marketing Reset – Part One
30 apr 2020
The Pharma Marketing Reset: Insights and Innovation
The radical change to deliver patient and customer-centric engagement
This 4-part white paper is written by SOPHIE STIEWE, a Graduate Marketing and Project Management Assistant at Uptake Strategies’. Sophie has a Master of Biochemistry in Molecular and Cellular Biochemistry from the University of Oxford. During her studies, she acquired a variety of practical experiences within the pharmaceutical industry via internships, competitions, and masterclasses at industry-leading companies. She is presently on a two-year fast track Graduate scheme and pursuing her interest in marketing by studying towards a CIM Diploma in Professional Marketing.
Part 1: Insight
Generating insight remains a critical undertaking in which every pharma / biotech company strives to excel in underpinning their marketing strategy. The rise of digital technologies has left pharma marketers with a new dilemma. A wealth of new data sources has become available, yet the increasing amount of data has not yet improved the identification of insights as much as might have been hoped. Moreover, the insights generated tend still to be confined to diagnostic insights, for example, explaining current trends, rather than creating value for future decision making.
In the first of our 4-part series ‘The Pharma Marketing Reset’ exploring insights, we share:
- Some of the biggest challenges marketers currently face when generating insights
- New data sources and inspiration from other industries to drive better insight
- Recommendations on how to ensure your brand team has the necessary insight capabilities to set them up for success!
If you would like to read Part 1 of this white paper contact Lauren.Pearson@uptakestrategies.com.